Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Sesh+

Sesh+ sells innovative risk-reduced nicotine products with a mission of eliminating tobacco related harm.
2020
02-Oct
02-10
Vancouver, British Columbia, Canada
  • Smokeless Tobacco Products
  • Vapes, E-Cigarettes, and HNB

Innovation

Industry Problem

Adult nicotine users seek tobacco-free formats that avoid smoke and the handling of loose tobacco.

R&D Focus

Synthetic-nicotine oral pouches, flavor delivery and pouch formulation.

Innovative Solution

Tobacco-free pouches formulated with pharmaceutical-grade synthetic nicotine beta-cyclodextrin, gum base and flavor systems.

Solution Effectiveness

The company recommends use for up to 30 minutes. Product pages show customer ratings of about 4.2 to 4.6 out of 5 for several bestselling flavors; these are customer reviews, not clinical evidence.

Investment Funding

Last Funding Stage

Debt Financing

Total Funding Amount

13.45M

Last Funding Amount

4.74M

Last Funding Date

08-07-2024

People

Founders

About

Sesh+ sells innovative risk-reduced nicotine products with a mission of eliminating tobacco related harm.

Products

Product

Sesh+ nicotine pouches in 4 mg, 6 mg and 8 mg strengths, including Mint, Wintergreen, Clear and Raspberry Lemon.

Star Product

Sesh+ Mint, because the company lists it among its bestsellers and it has broad strength availability.

Demo Product or Complete Product?

Complete commercial product sold online and through selected US stores.

Future Plan

Market Expansion

The company continues adding US retail locations and distribution channels.

Something missing or incorrect on this page? Help us enrich this information